Blog

Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management

Photos of Ahmad Tarhini and Patrick Hwu

Jun 6, 2024, 06:30

Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management

Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute, shared on LinkedIn: .

“Chatting with Dr. Patrick Hwu about the latest advances in melanoma management including neoadjuvant immunotherapy as a new standard of care, triplet immuno-oncology combinations, and our efforts in biomarker development to better select the right treatment for our patients.”

Proceed to the video.
Source: Ahmad Tarhini/LinkedIn

Ahmad Tarhini ASCO ASCO24 biomarker development cancer immuno-oncology combinations Melanoma melanoma management Moffitt Cancer Center neoadjuvant immunotherapy OncoDaily Oncology Patrick Hwu Precision Medicine

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer